Mindray Medical (300760.SZ) expects overall revenue in the third quarter to achieve year-on-year growth.

Finance and Economics APP News, Mindray Medical (300760.SZ) disclosed its main business situation in the third quarter of 2025. According to the company's preliminary calculations, the overall operating income of the company in the third quarter of 2025 will achieve a year-on-year positive growth, while the trend of improving operating income on a quarterly basis will continue. Among them: the year-on-year growth of the international market in the third quarter has accelerated, and the international in vitro diagnostic product line is expected to achieve rapid growth; the domestic market will significantly improve and reach a turning point on schedule.